TNFα in cerebral ischemia: another stroke against you?

PubWeight™: 0.75‹?›

🔗 View Article (PMID 25656781)

Published in J Neurochem on February 05, 2015

Authors

Heather M Wilkins1, Russell H Swerdlow

Author Affiliations

1: The Alzheimer's Disease Center and the Departments of Neurology, Molecular and Integrative Physiology, and Biochemistry and Molecular Biology, University of Kansas School of Medicine, Kansas City, Kansas, USA.

Articles by these authors

Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids. Nat Genet (2011) 2.76

Complex I deficiency in Parkinson's disease frontal cortex. Brain Res (2007) 1.61

Mitochondria dysfunction of Alzheimer's disease cybrids enhances Abeta toxicity. J Neurochem (2004) 1.58

DNA extraction procedures meaningfully influence qPCR-based mtDNA copy number determination. Mitochondrion (2009) 1.50

Ubiquitin proteasome system in Parkinson's disease: a keeper or a witness? Exp Neurol (2012) 1.50

Heat treatment improves glucose tolerance and prevents skeletal muscle insulin resistance in rats fed a high-fat diet. Diabetes (2008) 1.47

Reduced lean mass in early Alzheimer disease and its association with brain atrophy. Arch Neurol (2010) 1.47

Mitochondrial haplotypes associated with biomarkers for Alzheimer's disease. PLoS One (2013) 1.47

Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease. Neurology (2011) 1.23

The thiazolidinedione pioglitazone alters mitochondrial function in human neuron-like cells. Mol Pharmacol (2007) 1.18

MRI characteristics and scoring in HDLS due to CSF1R gene mutations. Neurology (2012) 1.17

Regulation of neuron mitochondrial biogenesis and relevance to brain health. Biochim Biophys Acta (2009) 1.17

Maternal transmission of Alzheimer's disease: prodromal metabolic phenotype and the search for genes. Hum Genomics (2010) 1.12

Oxidative stress involvement in alpha-synuclein oligomerization in Parkinson's disease cybrids. Antioxid Redox Signal (2009) 1.08

Hyperglycemia alters the schwann cell mitochondrial proteome and decreases coupled respiration in the absence of superoxide production. J Proteome Res (2010) 1.08

Mitochondrial function in Parkinson's disease cybrids containing an nt2 neuron-like nuclear background. Mitochondrion (2008) 1.07

Right orbitofrontal tumor with pedophilia symptom and constructional apraxia sign. Arch Neurol (2003) 1.05

Mitochondrial dysfunction and caspase activation in rat cortical neurons treated with cocaine or amphetamine. Brain Res (2006) 1.05

Cardiorespiratory fitness is associated with atrophy in Alzheimer's and aging over 2 years. Neurobiol Aging (2011) 1.05

Reduced mitochondria cytochrome oxidase activity in adult children of mothers with Alzheimer's disease. J Alzheimers Dis (2011) 1.04

Insulin is differentially related to cognitive decline and atrophy in Alzheimer's disease and aging. Biochim Biophys Acta (2011) 1.03

Parkinsonian features in hereditary diffuse leukoencephalopathy with spheroids (HDLS) and CSF1R mutations. Parkinsonism Relat Disord (2013) 1.02

Mitochondrial abnormalities in cybrid cell models of sporadic Alzheimer's disease worsen with passage in culture. Neurobiol Dis (2004) 1.01

Induction of cytochrome c-mediated apoptosis by amyloid beta 25-35 requires functional mitochondria. Brain Res (2002) 0.98

Mitochondria in neurodegeneration. Adv Exp Med Biol (2012) 0.97

Dysfunctional mitochondria uphold calpain activation: contribution to Parkinson's disease pathology. Neurobiol Dis (2009) 0.97

Cell and animal models of mtDNA biology: progress and prospects. Am J Physiol Cell Physiol (2006) 0.96

Bioenergetic flux, mitochondrial mass and mitochondrial morphology dynamics in AD and MCI cybrid cell lines. Hum Mol Genet (2013) 0.96

Mitochondrial respiration and respiration-associated proteins in cell lines created through Parkinson's subject mitochondrial transfer. J Neurochem (2010) 0.96

Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. Proc Natl Acad Sci U S A (2012) 0.95

Role of mitochondrial homeostasis and dynamics in Alzheimer's disease. Neurobiol Dis (2012) 0.93

Lactate administration reproduces specific brain and liver exercise-related changes. J Neurochem (2013) 0.92

Microtubule depolymerization potentiates alpha-synuclein oligomerization. Front Aging Neurosci (2010) 0.92

Mitochondrial metabolism in Parkinson's disease impairs quality control autophagy by hampering microtubule-dependent traffic. Hum Mol Genet (2012) 0.91

Ncb5or deficiency increases fatty acid catabolism and oxidative stress. J Biol Chem (2011) 0.90

Rapamycin drives selection against a pathogenic heteroplasmic mitochondrial DNA mutation. Hum Mol Genet (2013) 0.89

Altered neurochemical profile after traumatic brain injury: (1)H-MRS biomarkers of pathological mechanisms. J Cereb Blood Flow Metab (2012) 0.89

Mitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic intervention. Adv Pharmacol (2012) 0.89

Mitochondria and ubiquitin-proteasomal system interplay: relevance to Parkinson's disease. Free Radic Biol Med (2008) 0.88

Polyunsaturated fatty acids mobilize intracellular Ca2+ in NT2 human teratocarcinoma cells by causing release of Ca2+ from mitochondria. Am J Physiol Cell Physiol (2006) 0.86

Polymorphic variation in cytochrome oxidase subunit genes. J Alzheimers Dis (2010) 0.85

Effect of exercise on mouse liver and brain bioenergetic infrastructures. Exp Physiol (2012) 0.84

Mitochondria-derived oxidative stress induces a heat shock protein response. J Neurosci Res (2004) 0.84

Regulation of mitochondrial function and cellular energy metabolism by protein kinase C-λ/ι: a novel mode of balancing pluripotency. Stem Cells (2014) 0.84

Maternal family history is associated with Alzheimer's disease biomarkers. J Alzheimers Dis (2012) 0.84

Alternate day fasting impacts the brain insulin-signaling pathway of young adult male C57BL/6 mice. J Neurochem (2011) 0.81

Consumption of polyphenol plants may slow aging and associated diseases. Curr Pharm Des (2013) 0.81

Short-term effect of dementia disclosure: how patients and families describe the diagnosis. J Am Geriatr Soc (2006) 0.80

Effect of one month duration ketogenic and non-ketogenic high fat diets on mouse brain bioenergetic infrastructure. J Bioenerg Biomembr (2014) 0.80

Molecular characterization of mtDNA depleted and repleted NT2 cell lines. Mitochondrion (2005) 0.79

Nerve growth factor attenuates oxidant-induced β-amyloid neurotoxicity in sporadic Alzheimer's disease cybrids. J Neurochem (2010) 0.78

Potentiation of dietary restriction-induced lifespan extension by polyphenols. Biochim Biophys Acta (2012) 0.78

Calpain-mediated MPP+ toxicity in mitochondrial DNA depleted cells. Neurotox Res (2008) 0.78

"Untangling" the relationship between Alzheimer disease and dementia with Lewy bodies. Neurology (2012) 0.78

An Alzheimer disease presenilin mutation, syndrome diversity, and a shrinking world. Neurology (2010) 0.77

β-Apptists and Tauists, it is time for a sermon from the book of biogenesis. J Neurochem (2012) 0.77

Fatal encephalitis in a patient with refractory celiac disease presenting with myorhythmia and carpal spasm. Mov Disord (2007) 0.77

Effects of memantine on mitochondrial function. Biochem Pharmacol (2007) 0.77

Effect of cholinergic signaling on neuronal cell bioenergetics. J Alzheimers Dis (2013) 0.76

A cybrid cell model for the assessment of the link between mitochondrial deficits and sporadic Parkinson's disease. Methods Mol Biol (2015) 0.76

Backwaters and rapids on the amyloid river. Neurology (2013) 0.76

For Alzheimer disease GWAS, pulling needles from the haystack is just the first step. Neurology (2012) 0.76

Mitochondria and Parkinson's disease. Parkinsons Dis (2012) 0.76

Alzheimer disease: can the exam predict the pathology? Neurology (2012) 0.76

Differential regulation of intracellular calcium oscillations by mitochondria and gap junctions. Cell Biochem Biophys (2006) 0.75